E N Aleksandrova - JoVE Visualize

Showing results (81-90 of 109) with videos related to

Pageof 11

Sort By:

Terapevticheskii Arkhiv|July 17, 2014

[Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment]M É Tsanian, S K Solov'ev, A V Torgashina, et al.

Terapevticheskii Arkhiv|July 10, 2003

[Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]T M Reshetniak, Z S Alekberova, G P Kotel'nikova, et al.

Terapevticheskii Arkhiv|January 1, 1995

[Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome]Z S Alekberova, T M Reshetniak, S G Rodenska-Lopovok, et al.

Terapevticheskii Arkhiv|August 12, 2009

[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]D S Novikova, T V Korotaeva, E Iu Loginova, et al.

Terapevticheskii Arkhiv|December 3, 2005

[Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome]L A Kalashnikova, L A Dobrynina, N L Patrusheva, et al.

Terapevticheskii Arkhiv|December 25, 2008

[Anticitrulline antibodies and wrist joint MRI parameters in patients with early arthritis]D E Karateev, E N Aleksandrova, N V Demidova, et al.

Klinicheskaia Meditsina|August 11, 2001

[C-reactive protein and defect in lipid transport blood system in patients with rheumatoid arthritis]L N Kaznacheev, N V Perova, E N Aleksandrova, et al.

Terapevticheskii Arkhiv|January 1, 1996

[Arterial hypertension and the antiphospholipid syndrome]E L Nasonov, Iu A Karpov, Z S Alekberova, et al.

Terapevticheskii Arkhiv|December 2, 2009

[Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients]A E Il'ina, E I Varfolomeeva, A V Volkov, et al.

Terapevticheskii Arkhiv|August 12, 2009

[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]T A Lisitsyna, D Iu Vel'tishchev, O F Seravina, et al.

Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:

Pageof 11

Terapevticheskii Arkhiv|July 17, 2014

[Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment]M É Tsanian, S K Solov'ev, A V Torgashina, et al.

Terapevticheskii Arkhiv|July 10, 2003

[Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]T M Reshetniak, Z S Alekberova, G P Kotel'nikova, et al.

Terapevticheskii Arkhiv|January 1, 1995

[Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome]Z S Alekberova, T M Reshetniak, S G Rodenska-Lopovok, et al.

Terapevticheskii Arkhiv|August 12, 2009

[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]D S Novikova, T V Korotaeva, E Iu Loginova, et al.

Terapevticheskii Arkhiv|December 3, 2005

[Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome]L A Kalashnikova, L A Dobrynina, N L Patrusheva, et al.

Terapevticheskii Arkhiv|December 25, 2008

[Anticitrulline antibodies and wrist joint MRI parameters in patients with early arthritis]D E Karateev, E N Aleksandrova, N V Demidova, et al.

Klinicheskaia Meditsina|August 11, 2001

[C-reactive protein and defect in lipid transport blood system in patients with rheumatoid arthritis]L N Kaznacheev, N V Perova, E N Aleksandrova, et al.

Terapevticheskii Arkhiv|January 1, 1996

[Arterial hypertension and the antiphospholipid syndrome]E L Nasonov, Iu A Karpov, Z S Alekberova, et al.

Terapevticheskii Arkhiv|December 2, 2009

[Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients]A E Il'ina, E I Varfolomeeva, A V Volkov, et al.

Terapevticheskii Arkhiv|August 12, 2009

[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]T A Lisitsyna, D Iu Vel'tishchev, O F Seravina, et al.

Pageof 11